Sonova Holding AG (SONVF) Research

Sonova Holding AG, a Swiss-based company headquartered in Stäfa and established in 1947, stands as a premier global provider of comprehensive auditory health solutions designed for individuals of all ages. Its core business is structured into two main divisions: Hearing Instruments and Cochlear Implants. The company's expansive product and service offerings include state-of-the-art wireless communication technologies, innovative rechargeable hearing aids, a variety of headsets (including wireless models, speech-enhanced 'hearables,' and high-fidelity audiophile headphones), sophisticated microphones, and advanced wireless transmission systems. Complementing these products, Sonova also delivers a full suite of professional audiological care services. Sonova markets its diverse range of products under well-recognized brands: Phonak, Unitron, and Hansaton for its hearing instruments; Advanced Bionics for cochlear implants; and Sennheiser for its consumer hearing line. Its audiological care services are accessible through a wide network of subsidiary brands, such as AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton. The company employs a dual strategy for customer outreach: products are distributed globally through independent partners, while its hearing care services are provided directly via an extensive network comprising roughly 3,600 proprietary stores and clinics. With a significant international footprint, Sonova operates across major regions including the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company officially adopted its current name, Sonova Holding AG, in August 2007, having previously operated as Phonak Holding AG.

Open Sonova Holding AG (SONVF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.